HIV infection prevention
Infectious disease · 2017–2017
1decision
1medicine
1carried consumer input
3individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| tenofovir disoproxil maleate with emtricitabine Pre-exposure prophylaxis (PrEP) against HIV infection in adults at medium to high risk of infection. | Jul 2017 | Deferred | 3 individuals |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.